{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:04:48Z","timestamp":1790424288526,"version":"4.1.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-016-0456-3","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T13:27:48Z","timestamp":1484314068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study"],"prefix":"10.1186","volume":"17","author":[{"given":"Manal S.","family":"Fawzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Toraih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagwa M.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Fakhr-Eldeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahlia I.","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"456_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics-2014 update: a report from the American heart association. Circulation. 2014;129:399\u2013410.","journal-title":"Circulation"},{"key":"456_CR2","first-page":"137","volume":"15","author":"S Seef","year":"2013","unstructured":"Seef S, Jeppsson A, Stafstr\u00f6m M. What is killing? People\u2019s knowledge about coronary heart disease, attitude towards prevention and main risk reduction barriers in Ismailia, Egypt (descriptive cross-sectional study). Pan Afr Med J. 2013;15:137.","journal-title":"Pan Afr Med J"},{"key":"456_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/TCRM.S26414","volume":"8","author":"W Almahmeed","year":"2012","unstructured":"Almahmeed W, Arnaout MS, Chettaoui R, Ibrahim M, Kurdi MI, Taher MA, et al. Coronary artery disease in Africa and the Middle East. Ther Clin Risk Manag. 2012;8:65\u201372.","journal-title":"Ther Clin Risk Manag"},{"key":"456_CR4","first-page":"25","volume":"10","author":"L Liu","year":"2008","unstructured":"Liu L, Li Y, Tollefsbol TO. Gene-environment interactions and epigenetic basis of human diseases. Curr Issues Mol Biol. 2008;10:25\u201336.","journal-title":"Curr Issues Mol Biol"},{"key":"456_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4236\/ojgen.2011.13009","volume":"1","author":"M Raposo","year":"2011","unstructured":"Raposo M, Sousa P, Nemeth S, Couto A, Santos M, Pinheiro J, et al. Polymorphism in cardiovascular diseases (CVD) susceptibility loci in the azores islands (Portugal). Open J Genet. 2011;1:48\u201353.","journal-title":"Open J Genet"},{"key":"456_CR6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00439-009-0654-5","volume":"125","author":"H Roy","year":"2009","unstructured":"Roy H, Bhardwaj S, Yla-Herttuala S. Molecular genetics of atherosclerosis. Hum Genet. 2009;125:467\u201391.","journal-title":"Hum Genet"},{"key":"456_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/475163a","volume":"475","author":"CD Bustamante","year":"2011","unstructured":"Bustamante CD, Burchard EG, De la Vega FM. Genomics for the world. Nature. 2011;475:163\u20135.","journal-title":"Nature"},{"key":"456_CR8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ihj.2012.07.006","volume":"64","author":"G Himabindu","year":"2012","unstructured":"Himabindu G, Rajasekhar D, Latheef K, Sarma PVGK, Vanajakshamma V, Chaudhury A, et al. Factor V Leiden mutation is not a predisposing factor for acute coronary syndromes. Indian Heart J. 2012;64:570\u20135.","journal-title":"Indian Heart J"},{"key":"456_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.thromres.2013.06.007","volume":"132","author":"G Campo","year":"2013","unstructured":"Campo G, Pavasini R, Pollina A, Tebaldi M, Ferrari R. Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes. Thromb Res. 2013;132:151\u20137.","journal-title":"Thromb Res"},{"key":"456_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","volume":"13","author":"JL Kujovich","year":"2011","unstructured":"Kujovich JL. Factor V Leiden thrombophilia. Genet Med. 2011;13:1\u201316.","journal-title":"Genet Med"},{"key":"456_CR11","first-page":"1134","volume":"89","author":"F Burzotta","year":"2004","unstructured":"Burzotta F, Leone AM, Paciaroni K, De Stefano V, Rossi E, Testa L, et al. G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome. Haematologica. 2004;89:1134\u20138.","journal-title":"Haematologica"},{"key":"456_CR12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","volume":"367","author":"Z Ye","year":"2006","unstructured":"Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and controls. Lancet. 2006;367:651\u20138.","journal-title":"Lancet"},{"key":"456_CR13","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"SR Poort","year":"1996","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3\u2019-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698\u2013703.","journal-title":"Blood"},{"key":"456_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bpc.2004.07.023","volume":"112","author":"C Kobbervig","year":"2004","unstructured":"Kobbervig C, Williams E. FXIII polymorphisms, fibrin clot structure and thrombotic risk. Biophys Chem. 2004;112:223\u20138.","journal-title":"Biophys Chem"},{"key":"456_CR15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajh.1104","volume":"67","author":"D Gemmati","year":"2001","unstructured":"Gemmati D, Serino ML, Ongaro A, Tognazzo S, Moratelli S, Resca R, et al. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol. 2001;67:183\u20138.","journal-title":"Am J Hematol"},{"key":"456_CR16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1086\/303082","volume":"67","author":"PA Isotalo","year":"2000","unstructured":"Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet. 2000;67:986\u201390.","journal-title":"Am J Hum Genet"},{"key":"456_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.ejhg.5200767","volume":"10","author":"H Zetterberg","year":"2002","unstructured":"Zetterberg H, Regland B, Palmer M, Ricksten A, Palmqvist L, Rymo L, et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet. 2002;10:113\u20138.","journal-title":"Eur J Hum Genet"},{"key":"456_CR18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1160\/TH03-08-0546","volume":"91","author":"T Hoekstra","year":"2004","unstructured":"Hoekstra T, Geleijnse JM, Schouten EG, Kluft C. Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost. 2004;91:861\u201372.","journal-title":"Thromb Haemost"},{"key":"456_CR19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjcard.2012.11.060","volume":"111","author":"G Ndrepepa","year":"2013","unstructured":"Ndrepepa G, Braun S, King L, Fusaro M, Keta D, Cassese S, et al. Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2013;111:804\u201310.","journal-title":"Am J Cardiol"},{"key":"456_CR20","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/hc5001.100793","volume":"104","author":"SM Boekholdt","year":"2001","unstructured":"Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Buller HR, Peters RJ. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation. 2001;104:3063\u20138.","journal-title":"Circulation"},{"key":"456_CR21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1161\/01.STR.0000183617.54752.69","volume":"36","author":"K Jood","year":"2005","unstructured":"Jood K, Ladenvall P, Tjarnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, et al. Fibrinolytic gene polymorphism and ischemic stroke. Stroke. 2005;36:2077\u201381.","journal-title":"Stroke"},{"key":"456_CR22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.thromres.2009.02.017","volume":"125","author":"LS Rallidis","year":"2010","unstructured":"Rallidis LS, Gialeraki A, Fountoulaki K, Politou M, Sourides V, Travlou A, et al. G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece. Thromb Res. 2010;125:34\u20137.","journal-title":"Thromb Res"},{"key":"456_CR23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2141.2002.03864.x","volume":"119","author":"K Ghosh","year":"2002","unstructured":"Ghosh K, Kulkarni B, Nair S, Shetty S, Mohanty D. Human platelet alloantigen polymorphism in Glanzmann\u2019sthrombasthenia and its impact on the severity of the disease. Br J Haematol. 2002;119:348\u201353.","journal-title":"Br J Haematol"},{"key":"456_CR24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-9560-5-2","volume":"5","author":"R Loncar","year":"2007","unstructured":"Loncar R, Stoldt V, Hellmig S, Zotz RB, Mihalj M, Scharf RE. HPA-1 polymorphism of \u03b1IIb\u03b23 modulates platelet adhesion onto immobilized fibrinogen in an in-vitro flow system. Thromb J. 2007;5:2.","journal-title":"Thromb J"},{"key":"456_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-9560-12-17","volume":"12","author":"I Kutluturk","year":"2014","unstructured":"Kutluturk I, Karag\u00f6z A, Bezgin T, Oduncu V, Elveran A, Do\u011fan C, et al. Relationship between angiotensin I-converting enzyme insertion\/deletion gene polymorphism and retinal vein occlusion. Thromb J. 2014;12:17.","journal-title":"Thromb J"},{"key":"456_CR26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12291-011-0113-7","volume":"26","author":"E Farrokhi","year":"2011","unstructured":"Farrokhi E, Shayesteh F, Asadi Mobarakeh S, Roghani Dehkordi F, Ghatreh Samani K, Hashemzadeh CM. Molecular characterization of Iranian patients with possible familial hypercholesterolemia. Indian J Clin Biochem. 2011;26:244\u20138.","journal-title":"Indian J Clin Biochem"},{"key":"456_CR27","doi-asserted-by":"crossref","first-page":"e95463","DOI":"10.1371\/journal.pone.0095463","volume":"9","author":"G Zhang M-d","year":"2014","unstructured":"Zhang M-d G, Gu W, Qiao S-b, Zhu E-j, Zhao Q-m, Lv SZ. Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls. PLoS One. 2014;9:e95463.","journal-title":"PLoS One"},{"key":"456_CR28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/AC.66.4.2126597","volume":"66","author":"HM Kamal","year":"2011","unstructured":"Kamal HM, Ahmed AS, Fawzy MS, Mohamed FA, Elbaz AA. Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients. Acta Cardiol. 2011;66:483\u20138.","journal-title":"Acta Cardiol"},{"issue":"6","key":"456_CR29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2143\/AC.61.6.2017959","volume":"61","author":"H Saghafi","year":"2006","unstructured":"Saghafi H, Mahmoodi MJ, Fakhrzadeh H, Heshmat R, Shafaee A, Larijani B. Cardiovascular risk factors in first-degree relatives of patients with premature coronary artery disease. Acta Cardiol. 2006;61(6):607\u201313.","journal-title":"Acta Cardiol"},{"key":"456_CR30","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837\u201347.","journal-title":"Circulation"},{"key":"456_CR31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archinternmed.2009.516","volume":"170","author":"SL Sheridan","year":"2010","unstructured":"Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med. 2010;170:230\u20139.","journal-title":"Arch Intern Med"},{"key":"456_CR32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/gm230","volume":"3","author":"ACJ Janssens","year":"2011","unstructured":"Janssens ACJ, Ioannidis JP, van Duijn CM, Little J, Khoury MJ. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Genome Med. 2011;3:16.","journal-title":"Genome Med"},{"key":"456_CR33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08998280.2011.11928716","volume":"24","author":"JM Schussler","year":"2011","unstructured":"Schussler JM. Effectiveness and safety of transradial artery access for cardiac catheterization. Proc (Bayl Univ Med Cent). 2011;24:205\u20139.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"456_CR34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3329\/cardio.v8i1.24765","volume":"8","author":"T Saha","year":"2015","unstructured":"Saha T, Khalequzzaman M, Akanda A-k, Saha S, Tushar AZ, Ahmed R, et al. Association of GRACE risk score with angiographic severity of coronary artery disease in patients with ST elevation myocardial infarction. Cardiovasc J. 2015;8:30\u20134.","journal-title":"Cardiovasc J"},{"key":"456_CR35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jacc.2005.10.008","volume":"47","author":"R Scognamiglio","year":"2006","unstructured":"Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006;47:65\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"456_CR36","first-page":"120","volume":"102","author":"T G\u00f6kdeniz","year":"2014","unstructured":"G\u00f6kdeniz T, Kalayc\u0131o\u011flu E, Aykan A\u00c7, Boyac\u0131 F, Turan T, G\u00fc \u0130, et al. Value of coronary artery calcium score to predict severity or complexity of coronary artery disease. Arq Bras Cardiol. 2014;102:120\u20137.","journal-title":"Arq Bras Cardiol"},{"key":"456_CR37","first-page":"OC13","volume":"9","author":"G Khandelwal","year":"2015","unstructured":"Khandelwal G, Jain A, Rathore M. Prediction of angiographic extent of coronary artery disease on the basis of clinical risk scores in patients of unstable angina. J Clin Diagn Res. 2015;9:OC13\u20136.","journal-title":"J Clin Diagn Res"},{"key":"456_CR38","doi-asserted-by":"crossref","first-page":"857628","DOI":"10.1155\/2015\/857628","volume":"2015","author":"B \u00d6zdemir","year":"2015","unstructured":"\u00d6zdemir B, Em\u00fcl A, \u00d6zdemir L, Sa\u011f S, Bi\u00e7er M, Ayd\u0131nlar A. Association of aortic diameters with coronary artery disease severity and albumin excretion. Biomed Res Int. 2015;2015:857628.","journal-title":"Biomed Res Int"},{"key":"456_CR39","first-page":"166","volume-title":"Clinical chemistry: concepts and applications","author":"L Onaka","year":"1993","unstructured":"Onaka L. Lipids. In: Anderson SC, Cockayne S, editors. Clinical chemistry: concepts and applications. London: WB Saunders; 1993. p. 166\u201383."},{"key":"456_CR40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03260034","volume":"7","author":"MJ Kotze","year":"2003","unstructured":"Kotze MJ, Kriegsh\u00e4user G, Thiart R, de Villiers NJ, Scholtz CL, Kury F, et al. Simultaneous detection of multiple familial hypercholesterolemia mutations facilitates an improved diagnostic service in South African patients at high risk of cardiovascular disease. Mol Diagn. 2003;7:169\u201374.","journal-title":"Mol Diagn"},{"key":"456_CR41","unstructured":"Strip assay evaluator Web-edition, Release 2 (version 2.10). http:\/\/viennalab.sci-design.at\/webevaluator\/ . Accessed 14 Oct 2016."},{"key":"456_CR42","unstructured":"Online Encyclopedia for Genetic Epidemiology studies (OEGE). Hardy-Weinberg equilibrium calculator including analysis for ascertainment bias. http:\/\/www.oege.org\/software\/hardy-weinberg.html . Accessed 14 Oct 2016."},{"key":"456_CR43","doi-asserted-by":"crossref","first-page":"e0152834","DOI":"10.1371\/journal.pone.0152834","volume":"11","author":"MS Fawzy","year":"2016","unstructured":"Fawzy MS, Hussein MH, Abdelaziz EZ, Yamany HA, Ismail HM, Toraih EA. Association of MicroRNA-196a2 variant with response to short-acting \u03b22-agonist in COPD: an Egyptian pilot study. PLoS One. 2016;11:e0152834.","journal-title":"PLoS One"},{"key":"456_CR44","volume-title":"Multivariate analysis of ecological data, version 5.0 for windows","author":"B McCune","year":"2006","unstructured":"McCune B, Mefford MJPC-ORD. Multivariate analysis of ecological data, version 5.0 for windows. 2006."},{"key":"456_CR45","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1016\/S0828-282X(07)71000-0","volume":"23","author":"R Roberts","year":"2007","unstructured":"Roberts R, Stewart AF, Wells GA, Williams KA, Kavaslar N, McPherson R. Identifying genes for coronary artery disease: an idea whose time has come. Can J Cardiol. 2007;23:7A\u201315A.","journal-title":"Can J Cardiol"},{"key":"456_CR46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.MJX.0000407612.30230.96","volume":"10","author":"O Shaker","year":"2011","unstructured":"Shaker O, Fayez S, Zarouk W, Shehata M. Fibrinogen b-455\u00a0G\/A and prothrombin 20210\u00a0G\/A polymorphisms and coronary heart disease: an Egyptian case\u2013control study. Med Rese J. 2011;10:102\u20139.","journal-title":"Med Rese J"},{"key":"456_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4330\/wjc.v8.i1.1","volume":"8","author":"X Dai","year":"2016","unstructured":"Dai X, Wiernek S, Evans JP, Runge MS. Genetics of coronary artery disease and myocardial infarction. World J Cardiol. 2016;8:1\u201323.","journal-title":"World J Cardiol"},{"key":"456_CR48","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1182\/blood-2002-09-2888","volume":"101","author":"C Butt","year":"2003","unstructured":"Butt C, Zheng H, Randell E, Robb D, Parfrey P. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction. Blood. 2003;101:3037\u201341.","journal-title":"Blood"},{"key":"456_CR49","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/00313020600922934","volume":"38","author":"GS Zaatari","year":"2006","unstructured":"Zaatari GS, Otrock ZK, Sabbagh AS, Mahfouz RA. Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population. Pathology. 2006;38:442\u20134.","journal-title":"Pathology"},{"key":"456_CR50","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1160\/TH07-02-0150","volume":"98","author":"K Segers","year":"2007","unstructured":"Segers K, Dahlb\u00e4ck B, Nicolaes GA. Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost. 2007;98:530\u201342.","journal-title":"Thromb Haemost"},{"key":"456_CR51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0037-1616237","volume":"86","author":"I Martinelli","year":"2001","unstructured":"Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost. 2001;86:395\u2013403.","journal-title":"Thromb Haemost"},{"key":"456_CR52","first-page":"1410","volume":"44","author":"EA Trifonova","year":"2008","unstructured":"Trifonova EA, Spiridonova MG, Stepanov VA. Genetic diversity and the structure of linkage disequilibrium in the methylenetetrahydrofolate reductase locus. Genetika. 2008;44:1410\u20139.","journal-title":"Genetika"},{"key":"456_CR53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brainresbull.2006.01.005","volume":"69","author":"L Tajouri","year":"2006","unstructured":"Tajouri L, Martin V, Gasparini C, Ovcaric M, Curtain R, Lea RA, et al. Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis. Brain Res Bull. 2006;69:327\u201331.","journal-title":"Brain Res Bull"},{"key":"456_CR54","doi-asserted-by":"crossref","first-page":"e29134","DOI":"10.5812\/cardiovascmed.29134","volume":"5","author":"MM Heidari","year":"2015","unstructured":"Heidari MM, Khatami M, Hadadzadeh M, Kazemi M, Mahamed S, Malekzadeh P, et al. Polymorphisms in NOS3, MTHFR APOB and TNF-\u03b1 Genes and Risk of Coronary Atherosclerotic Lesions in Iranian Patients. Res Cardiovasc Med. 2015;5:e29134.","journal-title":"Res Cardiovasc Med"},{"key":"456_CR55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/B:THRO.0000040489.86029.27","volume":"17","author":"WY Almawi","year":"2004","unstructured":"Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR]) C677T gene polymorphism in angiographically documented coronary artery disease. J Thromb Thrombolysis. 2004;17:199\u2013205.","journal-title":"J Thromb Thrombolysis"},{"key":"456_CR56","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1590\/1516-3180.2013.1315500","volume":"131","author":"AI Neto","year":"2013","unstructured":"Neto AI, Moura Jr JR, Persuhn DC. Frequency of MTHFR G1793A polymorphism in individuals with early coronary artery disease: cross-sectional study. Sao Paulo Med J. 2013;131:296\u2013300.","journal-title":"Sao Paulo Med J"},{"key":"456_CR57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1160\/TH06-02-0117","volume":"96","author":"Y Yamada","year":"2006","unstructured":"Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Hibino T, et al. Assessment of genetic risk for myocardial infarction. Thromb Haemost. 2006;96:220\u20137.","journal-title":"Thromb Haemost"},{"key":"456_CR58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000316198.34558.e5","volume":"71","author":"M Sch\u00fcrks","year":"2008","unstructured":"Sch\u00fcrks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C\u2009>\u2009T polymorphism, migraine, and cardiovascular disease. Neurology. 2008;71:505\u201313.","journal-title":"Neurology"},{"key":"456_CR59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000022958","volume":"51","author":"LA Hsu","year":"2001","unstructured":"Hsu LA, Ko YL, Wang SM, Chang CJ, Hsu TS, Chiang CW, et al. The C677T mutation of the methylene tetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered. 2001;51:41\u20135.","journal-title":"Hum Hered"},{"key":"456_CR60","first-page":"234","volume":"37","author":"H Yilmaz","year":"2004","unstructured":"Yilmaz H, Agachan B, Ergen A, Karaalib ZE, Isbir T. Methylene tetrahydrofolate reductase C677T mutation and left ventricular hypertrophy in Turkish patients with type II diabetes mellitus. J Biochem Mol Biol. 2004;37:234\u20138.","journal-title":"J Biochem Mol Biol"},{"key":"456_CR61","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1590\/S1415-47572008005000023","volume":"31","author":"M Caner","year":"2008","unstructured":"Caner M, Bircan R, Sevin\u00e7 D, Benli F, G\u00fcney AI, Kurtoglu N. MTHFR, prothrombin and Factor V gene variants in Turkish patients with coronary artery stenosis. Genet Mol Biol. 2008;31:836\u20138.","journal-title":"Genet Mol Biol"},{"key":"456_CR62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/hq0701.093685","volume":"21","author":"MS Pepper","year":"2001","unstructured":"Pepper MS. Role of the matrix metalloproteinase and plasminogen activator plasmin systems in angiogenesis. Arterioscler Thromb Va-sc Biol. 2001;21:1104\u201317.","journal-title":"Arterioscler Thromb Va-sc Biol"},{"key":"456_CR63","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","volume":"14","author":"R Mehta","year":"2008","unstructured":"Mehta R, Shapiro A. Plasminogen activator inhibitor type 1 deficiency. Haemophilia. 2008;14:1255\u201360.","journal-title":"Haemophilia"},{"key":"456_CR64","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000083471.33820.3C","volume":"108","author":"JP Collet","year":"2003","unstructured":"Collet JP, Montalescot G, Vicaut E, Ankri A, Walylo F, Lesty C, et al. Acute release of plasminogen activator inhibitor-1 in ST segment elevation myocardial infarction predicts mortality. Circulation. 2003;108:391\u20134.","journal-title":"Circulation"},{"key":"456_CR65","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ahj.2006.06.021","volume":"152","author":"J Ding","year":"2006","unstructured":"Ding J, Nicklas BJ, Fallin MD, de Rekeneire N, Kritchevsky SB, Pahor M, et al. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke. Am Heart J. 2006;152:1109\u201315.","journal-title":"Am Heart J"},{"key":"456_CR66","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s10620-016-4156-8","volume":"61","author":"Y Li","year":"2016","unstructured":"Li Y, Di C, Li W, Cai W, Tan X, Xu L, et al. Oncomirs miRNA-221\/222 and tumor suppressors miRNA-199a\/195 Are crucial miRNAs in liver cancer: a systematic analysis. Dig Dis Sci. 2016;61:2315\u201327.","journal-title":"Dig Dis Sci"},{"key":"456_CR67","first-page":"3777","volume":"7","author":"H Zhang","year":"2014","unstructured":"Zhang H, Dong P, Yang X, Liu Z. Plasminogen activator inhibitor-1 4G\/5G polymorphism is associated with coronary artery disease risk: a meta-analysis. Int J Clin Exp Med. 2014;7:3777\u201388.","journal-title":"Int J Clin Exp Med"},{"key":"456_CR68","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.thromres.2007.09.005","volume":"122","author":"AE Tsantes","year":"2008","unstructured":"Tsantes AE, Nikolopoulos GK, Bagos PG, Bonovas S, Kopterides P, Vaiopoulos G. The effect of the plasminogen activator inhibitor-1 4G\/5G gene polymorphism on the thrombotic risk. Thromb Res. 2008;122:736\u201342.","journal-title":"Thromb Res"},{"key":"456_CR69","first-page":"32","volume":"8","author":"S Ismail","year":"2011","unstructured":"Ismail S, Abdel Azeem AA, Abdel Hamid MA, Nowier SR, Morad H. The role of 4G\/5G genetic polymorphism of plasminogen activator inhibitor-1 gene in myocardial infarction among Egyptians. Life Sci J. 2011;8:32\u20139.","journal-title":"Life Sci J"},{"key":"456_CR70","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0735-1097(99)00424-6","volume":"34","author":"JL Anderson","year":"1999","unstructured":"Anderson JL, Muhlestein JB, Habashi J, Carlquist JF, Bair TL, Elmer SP, et al. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. J Am Coll Cardiol. 1999;34:1778\u201383.","journal-title":"J Am Coll Cardiol"},{"key":"456_CR71","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1046\/j.1538-7836.2003.00255.x","volume":"1","author":"P Crainich","year":"2003","unstructured":"Crainich P, Jenny NS, Tang Z, Arnold AM, Kuller LH, Manolio T, et al. Lack of association of the plasminogen activator inhibitor-1 4G\/5G promoter polymorphism with cardiovascular disease in the elderly. J Thromb Haemost. 2003;1:1799\u2013804.","journal-title":"J Thromb Haemost"},{"key":"456_CR72","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.ijo.0803189","volume":"30","author":"I Mertens","year":"2006","unstructured":"Mertens I, Verrijken A, Michiels JJ, Van der Planken M, Ruige JB, Van Gaal LF. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes (Lond). 2006;30:1308\u201314.","journal-title":"Int J Obes (Lond)"},{"key":"456_CR73","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MOL.0b013e32814e6d29","volume":"18","author":"M-C Alessi","year":"2007","unstructured":"Alessi M-C, Poggi M, Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol. 2007;18:240\u20135.","journal-title":"Curr Opin Lipidol"},{"key":"456_CR74","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11010-012-1230-1","volume":"364","author":"KS Fernandes","year":"2012","unstructured":"Fernandes KS, Sandrim VC. 4G\/5G polymorphism modulates PAI-1 circulating levels in obese women. Mol Cell Biochem. 2012;364:299\u2013301.","journal-title":"Mol Cell Biochem"},{"key":"456_CR75","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/01.ATV.18.2.152","volume":"18","author":"M Margaglione","year":"1998","unstructured":"Margaglione M, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, Grandone E, et al. The PAI-1 gene locus 4G\/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:152\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"456_CR76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.ATV.11.1.183","volume":"11","author":"S Dawson","year":"1991","unstructured":"Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb. 1991;11:183\u201390.","journal-title":"Arterioscler Thromb"},{"key":"456_CR77","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/s-0038-1649833","volume":"74","author":"S Ye","year":"1995","unstructured":"Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, et al. The 4G\/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost. 1995;74:837\u201341.","journal-title":"Thromb Haemost"},{"key":"456_CR78","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(01)00292-4","volume":"103","author":"TK Nordt","year":"2001","unstructured":"Nordt TK, Lohrmann J, Bode C. Regulation of PAI-1 expression by genetic polymorphism. Impact on atherogenesis. Thromb Res. 2001;103:S1\u20135.","journal-title":"Thromb Res"},{"key":"456_CR79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0021-9150(94)05425-I","volume":"113","author":"M Eliasson","year":"1995","unstructured":"Eliasson M, Asplund K, Ervin PE, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin: the Northern Sweden MONICA study. Atherosclerosis. 1995;113:41\u201353.","journal-title":"Atherosclerosis"},{"key":"456_CR80","doi-asserted-by":"crossref","first-page":"204800401561025","DOI":"10.1177\/2048004015610252","volume":"4","author":"CN Floyd","year":"2015","unstructured":"Floyd CN, Ferro A, Warner TD. Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet function. JRSM Cardiovasc Dis. 2015;4:2048004015610252.","journal-title":"JRSM Cardiovasc Dis"},{"key":"456_CR81","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","volume":"83","author":"PJ Newman","year":"1989","unstructured":"Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 1989;83:1778\u201381.","journal-title":"J Clin Invest"},{"key":"456_CR82","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00001721-199707000-00004","volume":"8","author":"J Corral","year":"1997","unstructured":"Corral J, Gonz\u00e1lez-Conejero R, Rivera J, Iniesta JA, Lozano ML, Vicente V. HPA-1 genotype in arterial thrombosis-role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis. 1997;8:284\u201390.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"456_CR83","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM199604253341703","volume":"334","author":"EJ Weiss","year":"1996","unstructured":"Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334:1090\u20134.","journal-title":"N Engl J Med"},{"key":"456_CR84","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.carpath.2009.04.003","volume":"19","author":"N Abboud","year":"2010","unstructured":"Abboud N, Amin H, Ghazouani L, Ben Haj Khalifa S, Ben Khalafallah A, Aded F, Almawi WY, Mahjoub T. Polymorphisms of human platelet alloantigens HPA-1 and HPA-2 associated with severe coronary artery disease. Cardiovasc Pathol. 2010;19:302\u20137.","journal-title":"Cardiovasc Pathol."},{"key":"456_CR85","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood.V97.10.3093","volume":"97","author":"JS Bennett","year":"2001","unstructured":"Bennett JS, Catella-Lawson F, Rut AR, Vilaire G, Qi W, Kapoor SC, et al. Effect of the Pl (A2) alloantigen on the function of beta (3)-integrins in platelets. Blood. 2001;97:3093\u20139.","journal-title":"Blood"},{"key":"456_CR86","doi-asserted-by":"crossref","first-page":"e101518","DOI":"10.1371\/journal.pone.0101518","volume":"9","author":"CN Floyd","year":"2014","unstructured":"Floyd CN, Mustafa A, Ferro A. The PlA1\/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis. PLoS One. 2014;9:e101518.","journal-title":"PLoS One"},{"key":"456_CR87","doi-asserted-by":"crossref","first-page":"e100239","DOI":"10.1371\/journal.pone.0100239","volume":"9","author":"CN Floyd","year":"2014","unstructured":"Floyd CN, Ellis BH, Ferro A. The PlA1\/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis. PLoS One. 2014;9:e100239.","journal-title":"PLoS One"},{"key":"456_CR88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","volume":"336","author":"G Krasopoulos","year":"2008","unstructured":"Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 2008;336:195\u20138.","journal-title":"BMJ"},{"key":"456_CR89","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.99.8.999","volume":"99","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999\u20131004.","journal-title":"Circulation"},{"key":"456_CR90","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0008-6363(96)00222-2","volume":"33","author":"NJ Samani","year":"1997","unstructured":"Samani NJ, Lodwick D. Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res. 1997;33:693\u20137.","journal-title":"Cardiovasc Res"},{"key":"456_CR91","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2362.1998.00298.x","volume":"28","author":"L Scaglione","year":"1998","unstructured":"Scaglione L, Bergerone S, Gaschino G, Imazio M, Maccagnani A, Gambino R, et al. Lack of relationship between the P1A1\/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction. Eur J Clin Invest. 1998;28:385\u20138.","journal-title":"Eur J Clin Invest"},{"key":"456_CR92","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0037-1615644","volume":"85","author":"A Castelnuovo Di","year":"2001","unstructured":"Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1\/PLA2 and coronary risk: a meta-analysis. Thromb Haemost. 2001;85:626\u201333.","journal-title":"Thromb Haemost"},{"key":"456_CR93","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1538-7836.2005.01432.x","volume":"3","author":"RB Zotz","year":"2005","unstructured":"Zotz RB, Winkelmann BR, Mu\u00a8ller C, Boehm BO, Ma\u00a8rz W, Scharf RE. Association of polymorphisms of platelet membrane integrins \u03b1IIb\u03b23 (HPA-1b\/PlA2) and \u03b12\u03b21 (\u03b12807TT) with premature myocardial infarction. J Thromb Haemost. 2005;3:1522\u20139.","journal-title":"J Thromb Haemost"},{"key":"456_CR94","first-page":"557","volume":"30","author":"N Zeinali","year":"2015","unstructured":"Zeinali N, Hashemi M, Mirmohammadsadeghi M, Mirmohammadsadeghi H, Eskandari N, Sabzghabaee AM. Association of angiotensin-converting enzyme genotype, insertion\/deletion polymorphism and saphenous vein graft atherosclerosis in Iranian patients. Braz J Cardiovasc Surg. 2015;30:557\u201361.","journal-title":"Braz J Cardiovasc Surg"},{"key":"456_CR95","doi-asserted-by":"crossref","first-page":"e005627","DOI":"10.1136\/bmjopen-2014-005627","volume":"4","author":"P Demurtas","year":"2014","unstructured":"Demurtas P, Orr\u00f9 G, Coni P, Minerba L, Corrias M, Sirigu P, et al. Association between the ACE insertion\/deletion polymorphism and pterygium in Sardinian patients: a population based case\u2013control study. BMJ Open. 2014;4:e005627.","journal-title":"BMJ Open"},{"key":"456_CR96","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/359641a0","volume":"359","author":"F Cambien","year":"1992","unstructured":"Cambien F, Poirer O, Lecerf L, Evans A, Cambou J-P, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641\u20134.","journal-title":"Nature"},{"key":"456_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1681.1996.tb03054.x","volume":"23","author":"BJ Morris","year":"1996","unstructured":"Morris BJ. Hypothesis: an angiotensin converting enzyme genotype present in one in three Caucasians, is associated with increased mortality rate. Clin Exp Pharmacol Physiol. 1996;23:1\u201310.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"456_CR98","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1172\/JCI118369","volume":"96","author":"Y Oike","year":"1995","unstructured":"Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K. Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm: implication in the pathogenesis of myocardial infarction. J Clin Invest. 1995;96:2975\u20139.","journal-title":"J Clin Invest"},{"key":"456_CR99","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng1293-324","volume":"5","author":"M Ohishi","year":"1993","unstructured":"Ohishi M, Fujii K, Minamino T, Hagaki J, Kamitani A, Rakugi H, et al. A potent genetic risk factor for restenosis. (Letter). Nature Genet. 1993;5:324\u20135.","journal-title":"Nature Genet"},{"key":"456_CR100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.CIR.94.4.708","volume":"94","author":"NJ Samani","year":"1996","unstructured":"Samani NJ, Thompson JR, O\u2019Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996;94:708\u201312.","journal-title":"Circulation"},{"key":"456_CR101","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1470320311434242","volume":"13","author":"L Zhou","year":"2012","unstructured":"Zhou L, Xi B, Wei Y, Shen W, Li Y. Meta-analysis of the association between the insertion\/deletion polymorphism in ACE gene and coronary heart disease among the Chinese population. J Renin Angiotensin Aldosterone Syst. 2012;13:296\u2013304.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"456_CR102","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/01.CIR.101.17.2060","volume":"101","author":"J Higaki","year":"2000","unstructured":"Higaki J, Baba S, Katsuya T, Sato N, Ishikawa K, Mannami T, et al. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita Study. Circulation. 2000;101:2060\u20135.","journal-title":"Circulation"},{"key":"456_CR103","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/cs0930391","volume":"93","author":"R Butler","year":"1997","unstructured":"Butler R, Morris AD, Struthers AD. Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Sci. 1997;93:391\u2013400.","journal-title":"Clin Sci"},{"key":"456_CR104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s100380300007","volume":"48","author":"MD Bashyam","year":"2003","unstructured":"Bashyam MD, Savithri GR, Kumar MS, Narasimhan C, Nallari P. Molecular genetics of familial hypertrophic cardiomyopathy (FHC). J Hum Genet. 2003;48:55\u201364.","journal-title":"J Hum Genet"},{"key":"456_CR105","first-page":"698695","volume":"2012","author":"CH Tseng","year":"2012","unstructured":"Tseng CH, Tseng FH, Chong CK, Tseng CP, Cheng JC. Angiotensin-converting enzyme genotype and peripheral arterial disease in diabetic patients. Exp Diabetes Res. 2012;2012:698695.","journal-title":"Exp Diabetes Res"},{"key":"456_CR106","doi-asserted-by":"crossref","first-page":"e46495","DOI":"10.1371\/journal.pone.0046495","volume":"7","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Xu G, Liu D, Fan X, Zhu W, Liu X. Angiotensin-converting enzyme insertion\/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies. PLoS One. 2012;7:e46495.","journal-title":"PLoS One"},{"key":"456_CR107","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1365-2362.2003.01185.x","volume":"33","author":"C Fatini","year":"2003","unstructured":"Fatini C, Gensini F, Sticchi E, Battaglini B, Prisco D, Fedi S, et al. ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest. 2003;33:642\u20137.","journal-title":"Eur J Clin Invest"},{"key":"456_CR108","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM199503163321103","volume":"332","author":"K Lindpaintner","year":"1995","unstructured":"Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. New Eng J Med. 1995;332:706\u201311.","journal-title":"New Eng J Med"},{"key":"456_CR109","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","volume":"78","author":"AH Sprague","year":"2009","unstructured":"Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009;78:539\u201352.","journal-title":"Biochem Pharmacol"},{"key":"456_CR110","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","volume":"86","author":"B Rigat","year":"1990","unstructured":"Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343\u20136.","journal-title":"J Clin Invest"},{"key":"456_CR111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00439-004-1136-4","volume":"115","author":"T Suehiro","year":"2004","unstructured":"Suehiro T, Morita T, Inoue M, Kumon Y, Ikeda Y, Hashimoto K. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet. 2004;115:91\u20136.","journal-title":"Hum Genet"},{"key":"456_CR112","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1001\/archinternmed.2010.384","volume":"170","author":"H Shen","year":"2010","unstructured":"Shen H, Damcott CM, Rampersaud E, Pollin TI, Horenstein RB, McArdle PF, et al. Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish. Arch Intern Med. 2010;170:1850\u20135.","journal-title":"Arch Intern Med"},{"key":"456_CR113","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0021-9150(92)90056-M","volume":"96","author":"A Tybjaerg-Hansen","year":"1992","unstructured":"Tybjaerg-Hansen A, Humphries SE. Familial defective apolipoprotein B-100: A single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis. 1992;96:91\u2013107.","journal-title":"Atherosclerosis"},{"key":"456_CR114","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199805283382203","volume":"338","author":"A Tybjaerg-Hansen","year":"1998","unstructured":"Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med. 1998;338:1577\u201384.","journal-title":"N Engl J Med"},{"key":"456_CR115","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0022-2275(20)37419-8","volume":"38","author":"EH Ludwig","year":"1997","unstructured":"Ludwig EH, Hopkins PN, Allen A, Wu LL, Williams RR, Anderson JL, et al. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. J Lipid Res. 1997;38:1361\u201373.","journal-title":"J Lipid Res"},{"key":"456_CR116","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI1847","volume":"101","author":"J Bor\u00e9n","year":"1998","unstructured":"Bor\u00e9n J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J Clin Invest. 1998;101:1084\u201393.","journal-title":"J Clin Invest"},{"key":"456_CR117","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","volume":"160","author":"MA Austin","year":"2004","unstructured":"Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004;160:407\u201320.","journal-title":"Am J Epidemiol"},{"key":"456_CR118","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11033-006-9041-7","volume":"34","author":"AS Sabbagh","year":"2007","unstructured":"Sabbagh AS, Daher RT, Otrock ZK, Khalek RN, Zaatari GS, Mahfouz RA. ApoB-100 R3500Q mutation in the Lebanese population: prevalence and historical review of the literature. Mol Biol Rep. 2007;34:267\u201370.","journal-title":"Mol Biol Rep"},{"key":"456_CR119","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2350-6-6","volume":"6","author":"FM Zakharova","year":"2005","unstructured":"Zakharova FM, Damgaard D, Mandelshtam MY, Golubkov VI, Nissen PH, Nilsen GG, et al. Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia. BMC Med Genet. 2005;6:6.","journal-title":"BMC Med Genet"},{"key":"456_CR120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2004.12.042","volume":"180","author":"MM S\u00f6zen","year":"2005","unstructured":"S\u00f6zen MM, Whittall R, Oner C, Tokatli A, Kalkano\u011flu HS, Dursun A, et al. The molecular basis of familial hypercholesterolaemia in Turkish patients. Atherosclerosis. 2005;180:63\u201371.","journal-title":"Atherosclerosis"},{"key":"456_CR121","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.fob.2015.10.006","volume":"5","author":"YL Wang","year":"2015","unstructured":"Wang YL, Sun LM, Zhang L, Xu HT, Dong Z, Wang LQ, et al. Association between apolipoprotein E polymorphism and myocardial infarction risk: a systematic review and meta-analysis. FEBS Open Bio. 2015;5:852\u20138.","journal-title":"FEBS Open Bio"},{"key":"456_CR122","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1093\/nar\/gni155","volume":"33","author":"N Ghebranious","year":"2005","unstructured":"Ghebranious N, Ivacic L, Mallum J, Dokken C. Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology. Nucleic Acids Res. 2005;33:e149.","journal-title":"Nucleic Acids Res"},{"key":"456_CR123","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/CS20090488","volume":"118","author":"E McNeill","year":"2010","unstructured":"McNeill E, Channon KM, Greaves DR. Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. Clin Sci. 2010;118:641\u201355.","journal-title":"Clin Sci"},{"key":"456_CR124","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-9149(93)90732-R","volume":"71","author":"JE Eichner","year":"1993","unstructured":"Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 1993;71:160\u20135.","journal-title":"Am J Cardiol"},{"key":"456_CR125","first-page":"31","volume":"5","author":"P Ventakaramana","year":"1999","unstructured":"Ventakaramana P, Reddy C, Ferrell RE. Apolipoprotein E polymorphism in two populations of Andhra Pradesh. Ind J Hum Genet. 1999;5:31\u20135.","journal-title":"Ind J Hum Genet"},{"key":"456_CR126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02257924","volume":"2","author":"G Hergenc","year":"1995","unstructured":"Hergenc G, Taga Y, Emerk K, Cirakoglu B. Apolipoprotein E genotyping in Turkish myocardial infarction survivors and healthy controls. J Biomed Sci. 1995;2:46\u20139.","journal-title":"J Biomed Sci"},{"key":"456_CR127","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.5858\/1999-123-1241-ROAEPF","volume":"123","author":"N Dzimiri","year":"1999","unstructured":"Dzimiri N, Meyer BF, Hussain SS, Basco C, Afrane B, Halees Z. Relevance of apolipoprotein E polymorphism for coronary artery disease in the Saudi population. Arch Pathol Lab Med. 1999;123:1241\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"456_CR128","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/clinchem\/32.5.778","volume":"32","author":"HJ Lenzen","year":"1986","unstructured":"Lenzen HJ, Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem. 1986;32:778\u201381.","journal-title":"Clin Chem"},{"key":"456_CR129","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622\u201330.","journal-title":"Science"},{"key":"456_CR130","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.53.6.1308","volume":"53","author":"MO McCarron","year":"1999","unstructured":"McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology. 1999;53:1308\u201311.","journal-title":"Neurology"},{"key":"456_CR131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2004.07.002","volume":"177","author":"S Liu","year":"2004","unstructured":"Liu S, Song Y, Hu FB, Niu T, Ma J, Gaziano M, Stampfer MJ. A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1\/C3\/A4 gene cluster and risk of incident myocardial infarction in men. Atherosclerosis. 2004;177:119\u201326.","journal-title":"Atherosclerosis"},{"key":"456_CR132","doi-asserted-by":"crossref","first-page":"e104608","DOI":"10.1371\/journal.pone.0104608","volume":"9","author":"H Xu","year":"2014","unstructured":"Xu H, Li H, Liu J, Zhu D, Wang Z, Chen A, Zhao Q. Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction. PLoS One. 2014;9:e104608.","journal-title":"PLoS One"},{"key":"456_CR133","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4103\/0366-6999.156803","volume":"128","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Tang HQ, Peng WJ, Zhang BB, Liu M. Meta-analysis for the Association of Apolipoprotein E \u03b52\/\u03b53\/\u03b54 Polymorphism with Coronary Heart Disease. Chin Med J (Engl). 2015;128:1391\u20138.","journal-title":"Chin Med J (Engl)"},{"key":"456_CR134","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall Jr SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507\u201337.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"456_CR135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuroscience.2015.06.005","volume":"301","author":"L Jiang","year":"2015","unstructured":"Jiang L, Zhong J, Dou X, Cheng C, Huang Z, Sun X. Effects of ApoE on intracellular calcium levels and apoptosis of neurons after mechanical injury\u201d. Neuroscience. 2015;301:375\u201383.","journal-title":"Neuroscience"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0456-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T16:58:40Z","timestamp":1658422720000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0456-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":135,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0456-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"article-number":"26"}}